FDA approves Novartis' Elidel

The FDA granted marketing approval to Novartis (NVS; SWX:NOVN) for its Elidel pimecrolimus 1% cream to treat mild-to-moderate atopic dermatitis (eczema) in patients ages 2 and older who do not respond...